POLYMEDIX, INC Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2011-04: Study NCT01312935; Company role Lead sponsor; Phase Phase 2; Status Terminated.
- 2010-10: Study NCT01211470; Company role Lead sponsor; Phase Phase 2; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2011-04 | NCT01312935 Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI) | Lead sponsor | Phase 2 | Terminated | Percutaneous Coronary Intervention; Coronary Artery Disease (CAD); Angioplasty | 17 | 2012-08 |
| 2010-10 | NCT01211470 Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus | Lead sponsor | Phase 2 | Completed | Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA); (Susceptible or Methicillin Resistant) | 215 | 2012-03 |